PharmTeam

Seth Robey

Seth has always had a passion for scientific discovery, particularly biology and medicine. Seth studied biochemistry at Brandeis University. Now, as a PhD student of Molecular Pharmacology at Columbia University, Seth studies the drugs that help treat cardiac arrhythmias. He's thrilled to be a Motley Fool Contributor, and uncover new and exciting scientific discoveries that could improve our approach to medicine, and provide strong long term investments. Follow @SethRobey on twitter.

PharmTeam’s Activity

Fri Mar 28

Caps Pick

PharmTeam made a pick in CAPS. 9:48 AM

MannKind Corp (MNKD) will Underperform the S&P 500

Thu Mar 20

NL

Article

PharmTeam published an article 6:30 PM

A Major Confidence Boost for this Health Care IT Provider

Veeva Systems overcame two major hurdles in the most recent quarter. Is it time for smooth sailing?

Fri Mar 14

NL

Article

PharmTeam published an article 2:00 PM

The NIH is Investing in an Alzheimer's Cure; Should You?

Can any of the number of companies struggling to cure Alzheimer's disease provide reliable investments?

Mon Mar 10

Recommendation

PharmTeam recommended michaelservet's post on the Berkshire Hathaway board. 9:22 PM

Re: Earnings versus cash flow

Wed Mar 5

Article Comment

PharmTeam commented on an article. 3:34 PM

Does Athenahealth Inc's Growth Justify the Price?

Good analysis. I've been trying for months to get over the emotional hurdle of buying shares of a company trading at >2,000 P/E. I really do love management's vision for the company, and consider CEO Bush an intangible asset like

[more]

Thu Feb 27

Article Comment

PharmTeam commented on an article. 12:57 PM

AMC’s The Walking Dead: These 3 New Characters Could Change Everything

We all know the Alexandria safe zone is Fool HQ.

last week was definitely awesome. I'm not familiar with the comic and the idea that Eugene is a fraud, so my immediate impression after the episode was that

[more]

Wed Feb 26

NL

Article

PharmTeam published an article 11:38 AM

3 Things to Watch When Isis Pharmaceuticals Reports 2013 Earnings

This RNA therapeutics powerhouse should provide some insightful updates as it enters a critical point in its growth.

Tue Feb 18

CAPS Underperform Pitch

PharmTeam wrote about Prana Biotechnology Limited (ADR) (PRAN) . 10:43 AM

PRAN Underperform

Prana's drug for Huntington's achieved its primary endpoint in a Phase 2 trial, causing the stock to pop >20%. However, the primary endpoint addressed only safety and tolerability. Analysis of secondary efficacy endpoints showed that the drug did [more]

Caps Pick

PharmTeam made a pick in CAPS. 9:34 AM

Prana Biotechnology Limited (ADR) (PRAN) will Underperform the S&P 500

Thu Feb 13

NL

Article

PharmTeam published an article 11:59 PM

The Amazon.com and Facebook of Health Care

An investment in athenahealth is an investment in CEO Jonathan Bush's vision for an interconnected health care internet.

NL

Boards Post

PharmTeam posted to the Athena Health board. 10:45 AM

Is this still a buying opportunity?

Athena's done a great job targeting ambulatory health and small practices. With the Epocrates acquisition serving as a viral marketing tool, and partnerships with Cerner to link small practices to hospitals there's plenty of growth ahead. But a [more]

Wed Feb 12

NL

Article

PharmTeam published an article 8:30 AM

3 Trends That Could Define Drug Discovery in 2014

These clear trends could help investors identify winning companies in 2014 and beyond.

Sun Feb 9

Caps Pick

PharmTeam made a pick in CAPS. 11:56 AM

Quintiles Transnational Holdings Inc (Q) will Outperform the S&P 500

CAPS Outperform Pitch Reply

PharmTeam commented on TMFInnovator's pitch for VEEV. 11:40 AM

Thanks simon. I also really like the data sharing of veeva network as a moat against other CRM startups that don't have the scale to provide that kind of service. As you mentioned, veeva network should also be a very high margin product because they [more]

Fri Feb 7

CAPS Outperform Pitch

PharmTeam wrote about Fairway Market (FWM) . 11:19 AM

FWM Outperform

Well that was disappointing. I really like these stores as an alternative to Whole Foods and Trader Joes. The produce is excellent, a huge selection of brand name and private label foods, and really competitive prices. The store is always packed. [more]

Thu Feb 6

CAPS Outperform Pitch Reply

PharmTeam commented on TMFInnovator's pitch for VEEV. 1:28 PM

I really like the idea, and think the company could do really well as an industry-specific IT provider. But, do you think the market opportunity is large enough to make its valuation sustainable? There are only so many pharmaceutical companies, and [more]

Wed Feb 5

Caps Pick

PharmTeam made a pick in CAPS. 9:15 PM

Stratasys (SSYS) will Outperform the S&P 500

Caps Pick

PharmTeam made a pick in CAPS. 9:15 PM

3D Systems (DDD) will Outperform the S&P 500

Mon Feb 3

NL

Article

PharmTeam published an article 6:30 PM

Time for a Turnaround at Teva Pharmaceuticals Industries Ltd?

Are Teva's management and patent woes finally a thing of the past?

NL

Article

PharmTeam published an article 6:30 PM

Timing is Everything for this Health Care IT Provider

Veeva Systems has an innovative platform to meet the growing demand for cost-cutting in the health care sector.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 61.17
Player Rank 29333 out of 75542
Score 219.08
Score Change Today -19.47
Accuracy 51.43%
Active Picks 57
Total Picks 70
Best Pick PRAN (+77.60)
Worst Pick FWM (-63.67)
Average Score per Pick 3.13
Charms Earned 4
Highest Rated Favorite No Favorites Selected
Go to PharmTeam’s CAPS page

Boards Stats & Trivia

Board Posts 9
Recs Received 7
People who have rec'd these posts 7
Recs to Posts Ratio (last 30 days) N/A
Threads Started 5
Threads Started Percentage 55.56 %
Most Frequent Board Whole Foods Market, Inc.
Very First Post A SAS: Amazon.com post. (12/1/2013)
Percentage of Posts Rec'd 44.44 %
Show PharmTeam’s 10 Latest Posts